Last10K.com

Intellipharmaceutics International Inc. (IPCI) SEC Filing 6-K Foreign Issuer report for the period ending Monday, February 4, 2019

Intellipharmaceutics International Inc.

HISTORY TOOLS
CIK: 1474835 Ticker: IPCI

View differences made from one to another to evaluate Intellipharmaceutics International Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Intellipharmaceutics International Inc..

Continue

Assess how Intellipharmaceutics International Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Intellipharmaceutics International Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Intellipharmaceutics International Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: IPCI
CIK: 1474835
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001654954-19-001011
Submitted to the SEC: Mon Feb 04 2019 5:10:55 PM EST
Accepted by the SEC: Mon Feb 04 2019
Period: Monday, February 4, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/ipci/0001654954-19-001011.htm